• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Biogen Idec

Biogen Idec

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. FDA Approves Biogen Idec ’s ALPROLIX™, the First Hemophilia B Therapy to Reduce Bleeding Episodes with Prophylactic Infusions Starting at Least a Week Apart

    FDA Approves Biogen Idec ’s ALPROLIX™, the First Hemophilia B Therapy to Reduce Bleeding Episodes with Prophylactic Infusions Starting at Least a Week Apart

  2. Biogen Idec Hemophilia B Treatment Approved

    Biogen Idec Hemophilia B Treatment Approved

  3. FDA Approves Biogen Idec Treatment for Hemophilia B

    FDA Approves Biogen Idec Treatment for Hemophilia B

  4. UPDATE: Facebook, Biogen , Cal-Maine are stocks to watch

    UPDATE: Facebook, Biogen , Cal-Maine are stocks to watch

  5. UPDATE: U.S. stocks end week with losses

    UPDATE: U.S. stocks end week with losses

  6. MARKET SNAPSHOT: U.S. Stocks End Week With Losses

    MARKET SNAPSHOT: U.S. Stocks End Week With Losses

  7. Novartis Names New Alcon, Sandoz Division Heads

    Novartis Names New Alcon, Sandoz Division Heads

  8. UPDATE: Nu Skin rises after Chinese regulators issue small fine

    UPDATE: Nu Skin rises after Chinese regulators issue small fine

  9. UPDATE: U.S. stocks fall; Nasdaq skids 1.2%

    UPDATE: U.S. stocks fall; Nasdaq skids 1.2%

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.